miR-125a/b Regulates the Activation of Cancer Stem Cells in Paclitaxel-resistant Colon Cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Investigation

• Publication date

  2013-01-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3109/07357907.2012.743557PMID 23327190
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast cancer stem cells

  2013cited by this paper
• Upregulation of Proapoptotic MicroRNA mir-125a After Massive Small Bowel Resection in Rats

  2012cited by this paper
• Camptothecin Induces Apoptosis in Cancer Cells via MicroRNA-125b-Mediated Mitochondrial Pathways

  2012cited by this paper
• Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells

  2011cited by this paper
• The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells

  2011cited by this paper
• Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival

  2010cited by this paper
• Possibility of paclitaxel as an alternative radiosensitizer to 5-fluorouracil for colon cancer.

  2010cited by this paper
• Breast cancer stem cells

  2010cited by this paper
• Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia.

  2010cited by this paper
• Clusterin and chemoresistance.

  2009influential reference
• Treatment Resistance in Stem Cells and Breast Cancer

  2009cited by this paper
• Adjuvant chemotherapy for colon cancer in the elderly: moving from evidence to practice.

  2009cited by this paper
• ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells

  2009cited by this paper
• Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists

  2009cited by this paper
• Non-P 450 aldehyde oxidizing enzymes : the aldehyde dehydrogenase superfamily

  2009cited by this paper
• Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily

  2008cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase.

  2007cited by this paper
• Identification of a Primitive Brain–Derived Neural Stem Cell Population Based on Aldehyde Dehydrogenase Activity

  2006cited by this paper
• H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity

  2006cited by this paper
• Identification and analysis of microRNAs.

  2006cited by this paper
• Control of translation and mRNA degradation by miRNAs and siRNAs.

  2006cited by this paper
• Growth factor signaling and resistance to cancer chemotherapy.

  2004cited by this paper
• Enhancement of Hypoxia-Induced Tumor Cell Death In vitro and Radiation Therapy In vivo by Use of Small Interfering RNA Targeted to Hypoxia-Inducible Factor-1α

  2004cited by this paper
• Increased resistance of tumor cells to hyperthermia mediated by integrin-linked kinase.

  2003influential reference
• Prediction of mammalian microRNA targets.

  2003cited by this paper
• Cancerous stem cells can arise from pediatric brain tumors

  2003cited by this paper
• Enzymology of ethanol and acetaldehyde metabolism in mammals.

  1997cited by this paper

• CD44 knockdown alters miRNA expression and their target genes in colon cancer

  2025cites this paper
• Evaluation of epigenetic silencing of the miR-139-5p gene in the pathogenesis of colorectal cancer and its diagnostic biomarker capability in plasma samples

  2025cites this paper
• miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer

  2022cites this paper
• Exosomes and MicroRNAs in Biomedical Science

  2022cites this paper
• A novel epigenetic biomarker, plasma miR-138-5p gene promoter-methylated DNA, for colorectal cancer diagnosis.

  2022cites this paper
• MicroRNA Promoter Methylation in Colorectal Cancer

  2021cites this paper
• The impact of microRNAs on myeloid-derived suppressor cells in cancer.

  2021cites this paper
• Potential of miRNAs in cervical cancer chemoresistance

  2021cites this paper
• NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview

  2020cites this paper
• Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer.

  2020cites this paper
• Non-coding RNAs in drug resistance of head and neck cancers: A review.

  2020cites this paper
• Tumor mutation burden associated with miRNA-gene interaction outcome mediates the survival of patients with liver hepatocellular carcinoma

  2020cites this paper
• Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer

  2020cites this paper
• Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells

  2020cites this paper
• Hyper methylation of miRNA promotor in CRC :

  2019cites this paper
• From “Junk DNA” to Clinically Relevant Tools for Cancer Diagnosis, Staging, and Tailored Therapies: The Incredible Case of Non-Coding RNAs

  2019cites this paper
• Downregulation of MicroRNA-125a in Placenta Accreta Spectrum Disorders Contributes Antiapoptosis of Implantation Site Intermediate Trophoblasts by Targeting MCL1

  2019cites this paper
• Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells

  2019cites this paper
• Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma

  2018cites this paper
• Upregulation of let-7f-5p promotes chemotherapeutic resistance in colorectal cancer by directly repressing several pro-apoptotic proteins.

  2018cites this paper
• MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway

  2018cites this paper
• MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.

  2018cites this paper
• Computational modeling of methionine cycle-based metabolism and DNA methylation and the implications for anti-cancer drug response prediction

  2018cites this paper
• Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells.

  2018cites this paper
• The Network of Non-coding RNAs in Cancer Drug Resistance

  2018cites this paper
• MicroRNA: A new player in response to therapy for colorectal cancer

  2018cites this paper
• The role of microRNAs involved in PI3‐kinase signaling pathway in colorectal cancer

  2018cites this paper
• Association of Micro RNA (MiRNA) with Drug Resistance in Malignancies

  2018cites this paper
• Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam

  2017cites this paper
• Upregulation of microRNA-125b by G-CSF promotes metastasis in colorectal cancer

  2017cites this paper
• ALDH1A3 correlates with luminal phenotype in prostate cancer

  2017cites this paper
• Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance

  2017cites this paper
• MicroRNA-497 inhibits tumor growth through targeting insulin receptor substrate 1 in colorectal cancer

  2017cites this paper
• Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a

  2017cites this paper
• Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by hsa-miR-125a-3p via Modulation of Metastasis-Associated Protein 1 Signaling.

  2017cites this paper
• Cancer stem cells in human gastrointestinal cancer

  2016cites this paper
• MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer cells through targeting A20.

  2016cites this paper
• ALDH1A3, a metabolic target for cancer diagnosis and therapy

  2016influential citation
• Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.

  2016cites this paper
• Forkhead box Q1: A key player in the pathogenesis of tumors (Review).

  2016cites this paper
• Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer

  2016cites this paper
• Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells

  2016influential citation
• MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer.

  2016cites this paper
• MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression

  2016cites this paper
• MicroRNA-29b is a Novel Prognostic Marker in Colorectal Cancer

  2015cites this paper
• The Proportion of ALDEFLUOR-Positive Cancer Stem Cells Changes with Cell Culture Density Due to the Expression of Different ALDH Isoforms

  2015cites this paper
• ApoG2 inhibits the antiapoptotic protein, Mcl‑1, and induces mitochondria‑dependent apoptosis in human colorectal cancer cells.

  2015cites this paper
• Role of microRNAs in chemoresistance.

  2015cites this paper
• Concise Review: Custodians of the Transcriptome: How MicroRNAs Guard Stemness in Squamous Epithelia

  2015cites this paper
• Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs

  2014cites this paper
• MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance

  2014cites this paper
• MicroRNAs in colorectal cancer as markers and targets: Recent advances.

  2014cites this paper
• MicroRNAs in Cancer Drug Resistance and Drug Sensitivity

  2014cites this paper
• miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis

  2014cites this paper
• Activation of apoptotic pathway in normal, cancer ovarian cells by epothilone B.

  2013cites this paper
• Increasing sensitivity to drugs in leukemias by modulation of microRNA expression

  2013cites this paper